Paraneoplastic Ma antigen 5 promotes cellular processes of primary cells in ovarian endometriosis.

This study investigates the role of paraneoplastic Ma antigen 5 (PNMA 5), a member of the PNMA family of proteins, in ovarian endometriosis (EM). These proteins are known to play a significant role in various physiological activities and are highly expressed in cells undergoing carcinogenesis, where they influence cell cycle, apoptosis, and other cellular processes. However, the involvement of PNMA 5 in ovarian EM has not been fully understood. To explore this, the study analyzed PNMA 5 levels in both normal and ectopic endometrial tissues from ovarian EM patients using immunohistochemistry. Small interfering RNA (siRNA) was used to knock down PNMA 5 in ectopic tissue cells, and the effects of this intervention were assessed through qRT-PCR and western blot to evaluate the efficiency of knockdown. Additionally, CCK-8 assays, flow cytometry, transwell, and wound healing assays were employed to examine the impact of PNMA 5 on cell proliferation, apoptosis, migration, and invasion. The results demonstrated that PNMA 5 expression was significantly higher in ectopic tissues compared to normal endometrium. Moreover, the protein inhibited cell proliferation and invasion while promoting apoptosis in primary cells from ectopic tissues. These findings suggest that PNMA 5 could serve as a potential therapeutic target for EM, though further research is needed to fully understand its mechanisms.